Rheumatology відкриті
[search 0]
більше
Download the App!
show episodes
 
Artwork

1
Talking Rheumatology Spotlight

British Society for Rheumatology

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Щомісяця
 
Explore rheumatological conditions with the clinical experts. This monthly podcast covers everything from disease presentation to diagnosis, treatment and management. Some months, real cases are used to bring the discussion to life.
  continue reading
 
Editors at The Lancet Rheumatology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from disorders of the immune system to sex and gender in research design, the transitional care for adolescent patients with rheumatic diseases to care for undocumented immigrants, and more.
  continue reading
 
Artwork

1
MedEdTalks - Rheumatology

Vindico Medical Education

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Щомісяця
 
MedEdTalks Rheumatology is an accredited educational podcast for providers to learn more about treating patients with Rheumatology diseases/disorders. Discover all content and topics, by visiting mededtalks.com.
  continue reading
 
Artwork
 
The RheumMadness podcast is part of a rheumatology learning initiative started with the assistance of the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award. Go to https://sites.duke.edu/rheummadness/ to learn more. RheumMadness is created by David Leverenz, MD, who is the recipient of the CSE award.
  continue reading
 
Loading …
show series
 
Dr Yik Man speaks with Dr Marcela Ferrada about relapsing polychondritis. She brings a unique perspective to the discussion as both expert patient and rheumatologist. Typical clinical presentations to the future research agenda are covered and they even touch on VEXAS - a must listen. Reference - https://www.nature.com/articles/s41584-024-01113-9 T…
  continue reading
 
Interesting read this week - I cover a nifty little paper that presented data about adrenal insufficiency after stopping prednisolone, published in JAMA Open in March 2025. Open Access Journal Here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2831668Michael Putman
  continue reading
 
This is a joint podcast between The Lancet Rheumatology and The Lancet Regional Health - Western Pacific with Prof Xue Li. Biologics have become a mainstay of treatment in Rheumatology in Western populations, but in many parts of Asia, especially lower-and-middle-income countries, there remains substantial inequity in access due to differences in a…
  continue reading
 
In this podcast, Professor Savic talks about his recent publication that looks at treatment outcomes in patients with VEXAS syndrome, as well as what clinicians should look out for in patients (red flags), and future priorities for research. VEXAS syndrome (short for Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome) was first descr…
  continue reading
 
BSR has published a new set of management recommendations for ANCA-associated vasculitis (AAV), serving as an update to our AAV guideline last published in 2017. Find out more via our blog. Join guideline working group Chair, Lorraine Harper, and group members Rosemary Hollick, Harold Wilson-Morkeh, Georgina Ducker and expert by experience member, …
  continue reading
 
How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica? In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for…
  continue reading
 
This is the third and final episode of our mini-series on cell-based therapies in rheumatology, with Professor Fabian Müller and Dr Melanie Hagen from the Erlangen University, Germany. We discuss their recently published a study on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy in patients with autoimmune disease, as well as the …
  continue reading
 
This Talking Rheumatology Spotlight pod on burnout and mental health was recorded live at the BSR Annual Conference 2025. Pip Watson is joined by Gail Kinman (Professor of Occupational Health Psychology), Muzaffer Kaser (Consultant Psychiatrist) and Jacqui Clinch (Consultant Paediatric Rheumatologist and former Vice President of BSR). Burnout is a …
  continue reading
 
Join Dr Mariele Gatto in conversation with Dr Chris Wincup as they discuss all things related to lupus immunology, from pathogenesis to treatment decisions. Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @RheumatologyUK. BSR is the UK's leading specialist medical society for rheumatology and…
  continue reading
 
How can we improve time from symptom onset to axSpA diagnosis? In this episode, Dr Fabian Proft talks to Dr Antoni Chan about his fantastic work to reduce time to diagnosis in axial spondyloarthritis (axSpA) using an integrated referral and education system. They discuss the importance of a multi-pronged approach to education, as well as how clinic…
  continue reading
 
How do we approach a patient with rheumatic diseases who have cycled through multiple high cost drugs? In this pod, Dr Roz Benson, BSR Digital Learning Editor chats with Dr Arti Mahto, a consultant rheumatologist. They talk through some challenging cases discussed in the virtual biologics clinic and the role of the MDT in complex decision making. T…
  continue reading
 
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449Michael Putman
  continue reading
 
This is the second episode of a mini series on cell-based therapies in rheumatology, with Prof. Dominique Farge discussing the use of allogeneic umbilical cord-derived mesenchymal stromal cells (MSCs) as treatment for systemic lupus erythematosus (SLE). We cover the limited options currently available for people with severe or refractory SLE, the c…
  continue reading
 
This week I cover another of my newsletters, though I mostly use it as a skeleton to riff on a common (and challenging) issue for rheumatology consultants; diagnosing HLH. Check out the guidelines themselves here and have a listen to the podcast! https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(23)00273-4/fulltext…
  continue reading
 
In this episode, we recap the final results of RheumMadness 2025 and say thank you to our may contributors. If you haven't already, complete our RheumMadness 2025 post-survey here: https://duke.qualtrics.com/jfe/form/SV_1H1cHULbm0R1XWS To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.…
  continue reading
 
BSR has published an update to the axial spondyloarthritis guideline. It's almost 10 years since the last iteration of the guideline. Our understanding and awareness of the disease has increased enormously. We now have 10 different therapies licensed for advanced management of axial spondyloarthritis, which are broadly divided into three different …
  continue reading
 
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965Michael Putman
  continue reading
 
In this episode, we breakdown our reactions to the first round of RheumMadness 2025, plus we reveal which teams the participants liked the most in their brackets. To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @…
  continue reading
 
In this bonus case based episode Dr Steph Gall from the BSR digital learning board discusses an interesting case of muscle weakness with Dr Lisa Waters a Consultant in Rheumatology and Acute Medicine from Manchester. Can you work out what's going on? Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or twe…
  continue reading
 
Reminder to Submit your brackets by March 31, 2025 at 11:59pm ET! Link to the RheumMadness OnePager by Dr. Mithu Maheswaranathan (@MithuRheum) To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.so…
  continue reading
 
The first episode of a mini series on cell-based therapies in rheumatology, with Prof Rebecca Marsh and Grant Schulert discussing the use of allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease. Read the full article: https://www.thelancet.com/journals/la…
  continue reading
 
BSR has published a new guideline for the assessment and management of foot problems in adults, children and young people with inflammatory arthritis. Foot problems are almost universal in people with inflammatory arthritis, and virtually all people with inflammatory arthritis will experience foot problems at some point in the course of their disea…
  continue reading
 
In this episode, the RheumMadness leadership team discusses our approach to RheumMadness bracketology, including our favorites, dark horses, and read on the Blue Ribbon Panel. Submit your brackets by March 31, 2025 at 11:59pm ET! To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.e…
  continue reading
 
Roz Benson (digital learning editor) talks to consultant rheumatologist Dr Lizzy MacPhie and Resident doctor Nouran Abdou about a recent project digging deep into the reasons prisoners face difficulty in accessing care in the rheumatology clinic. This excellent project showcases how quality improvement can be a tool in helping to approach and reduc…
  continue reading
 
In this episode, we introduce the rest of the Blue Ribbon Panel and interview our friends from NephMadness about their CAR-T region. Remember, RheumMadness brackets are open through March 31 at 11:59pm ET! Submit your brackets here. First time playing RheumMadness? Check out our new explainer video! Blue Ribbon Panelists in this episode: Anastasiya…
  continue reading
 
What do you do when observational data and RCTs conflict? This week I'm covering the "real world PEXIVAS" study that was done by the French Vasculitis Study Group. Great read, interesting issues, have a listen and be sure to share with friends!Michael Putman
  continue reading
 
In this episode, we introduce 2 of our fantastic Blue Ribbon Panel members. Their full bios are listed below. You'll meet the rest of the panel in the next episode! Also, RheumMadness brackets are open through March 31 at 11:59pm ET! Submit your brackets here. First time playing RheumMadness? Check out our new explainer video! Panelists in this pod…
  continue reading
 
In this podcast, Jess Little, specialist MSK physiotherapist, talks to Professor Neil Basu, academic Rheumatologist and Professor Lorna Paul, professor of allied health science about fatigue and particularly what we can do to help patients. It covers everything from the importance to patients of considering fatigue to interventions including the ro…
  continue reading
 
In this podcast, Kathryn Rigler, Rheumatology specialist physiotherapist, talks to Poppy Greenman, Paediatric occupational therapist, covering how to talk to children and young people about fatigue, measuring fatigue and strategies to overcome it, with practical tips from an expert in this area Thanks for listening to Talking Rheumatology! Join the…
  continue reading
 
In this episode we are joined by some amazing collaborators from the EMEUNET to talk about the STRAP trials. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship Program CD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship Program…
  continue reading
 
Dr Bryant England discusses the use of TNF-inhibitor versus non-TNF inhibitor biological or targeted synthetic DMARDs for treatment of rheumatoid arthritis-associated ILD, and the effects on survival and respiratory hospitalisation outcomes. Read the full article: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00265-0/fulltext?d…
  continue reading
 
In this episode we discuss obinutuzumab for lupus nephritis and anti-CD19 CAR T Cell therapy for autoimmune rheumatic disease. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship Program CD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology …
  continue reading
 
In this episode we present part 2 of our conversation about the teams in the Full Court Care Champions region of RheumMadness 2025! Links to the Full Court Care Champions Scouting Reports: Cost-effectiveness of hydroxychloroquine retinopathy screening, by residents from the Lankenau Medical Center Internal Medicine Residency Program Steroid dose in…
  continue reading
 
One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies. Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150…
  continue reading
 
In this episode we dive into the teams in the Full Court Care Champions region of RheumMadness 2025! Links to the Full Court Care Champions Scouting Reports: Cost-effectiveness of hydroxychloroquine retinopathy screening, by residents from the Lankenau Medical Center Internal Medicine Residency Program Steroid dose in lupus nephritis, by the Washin…
  continue reading
 
Dr Ashely Elliot speaks to respiratory consultant Dr Nazia Chaudhuri about interstitial lung disease. This overview covers everything from diagnosing CTD- ILD and an evidenced based management approach to poor prognostic risk factors. Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @Rheumatol…
  continue reading
 
Podcast this week about overdiagnosis! Currently one of my favorite topics and something that I think will be an emerging issue in our field. We recently published a Viewpoint in Lancet Rheumatology (https://pubmed.ncbi.nlm.nih.gov/39341221/) addressing this issue. I'm going to read from it and after that will be giving a few final (spicy) thoughts…
  continue reading
 
This episode contains part 2 of our conversation with Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, about the Cytokine Crushers region of RheumMadness 2025. In this episode, we focus specifically on the TYK2 in SLE and Oral Anti-IL23 teams. Links to the Cytokine Crushers Scouting Reports: Oral anti-IL23,…
  continue reading
 
Dr Brooke Conley and Associate Professor Ivan Lin discuss their recent study on integrating evidence from lived experience of Aboriginal people and clinical practice guidelines to develop arthritis educational resources. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup h…
  continue reading
 
In this episode, we are joined by Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, to discuss the teams in the Cytokine Crushers region of RheumMadness 2025, the Innovation Invitational. This is part 1 of the conversation, where we go in depth about the long-term outcomes of anifrolumab in SLE study and giv…
  continue reading
 
In this episode, we present the second part of our conversation with the authors of the scouting reports for the teams in the T'd Up T-cells region of RheumMadness 2025: the Innovation Invitational. Plus, we highlight Q&As from theMednet.org about the T'd Up T-Cells teams AND record an interview with Dr. Bill St. Clair, the first author of the phas…
  continue reading
 
In this episode, we dive in to the T'd Up T-cells region of RheumMadness 2025: the Innovation Invitational. This is the first of a two-part conversation with the authors of the scouting reports for the teams in this region. Check back next week to hear the rest of the conversation! To find the scouting reports and base articles discussed in this ep…
  continue reading
 
Welcome back to RheumMadness, the place for everyone who is crazy about rheumatology to connect, collaborate, compete, and learn together. The podcast took a hiatus in 2024 (hence why there are no episodes labeled season 4), but we we are thrilled to announce that the podcast is back for 2025 and beyond. In this episode, we explain some changes to …
  continue reading
 
In this Talking Rheumatology bonus case based episode Dr Roz Benson talks to Dr Susie Brockbank about an interesting and unusual case involving joint pain, GI involvement and some other systems. Can you work out what's going on? Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @RheumatologyUK.…
  continue reading
 
Dr Mark Russell and Sherry Yang discuss the factors influencing initiation of biologics in underserved populations with rheumatoid arthritis in the UK, how historical redlining and present-day racialised economic segregation affects health-care utilisation of adults with rheumatic diseases in the USA, and health inequities seen in rheumatology more…
  continue reading
 
In this Talking Rheumatology bonus case based episode Dr Laura Chadwick talks to Prof Rob Moots about an interesting and unusual case involving joint pain and chest pain . Can you work out what's going on? Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @RheumatologyUK. BSR is the UK's leadin…
  continue reading
 
In this pod, Roz Benson talks to consultant nurse Sarah Hardy and vasculitis expert Dr Shirish Dubey. This wide ranging discussion about vasculitis covers everything from diagnostic tips and approach to management, to the practicalities of a kidney biopsy and cyclophosphamide counselling. Thanks for listening to Talking Rheumatology! Join the conve…
  continue reading
 
In this episode of our Innovators mini-series, Amanda Mootoo, Mariam Malik and Nick Sands join Lizzy MacPhie to explore the role of a Chief Registrar. Whether you're a trainee interested in the Chief Registrar role and how it gives unique access to leadership and management training and experience, or if you are a member of a senior management team…
  continue reading
 
This is the second episode of a mini-series hosted by Dr Judith Jade where she explores the importance of our response to failure with prominent leaders in rheumatology. In this episode Dr Judith Jade talks to Will Gregory, a Rheumatology Consultant Physiotherapist at Salford Royal Hospital and our new BSR Vice President, about things that didn't g…
  continue reading
 
Loading …

Короткий довідник

Слухайте це шоу, досліджуючи
Відтворити